RecruitingNCT07505875

Pre-implementation Study to Develop Trans-tailored Services for Transgender Persons in Relation to chemsEX


Sponsor

Institute of HIV Research and Innovation Foundation, Thailand

Enrollment

50 participants

Start Date

May 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The study is a pre-implementation cross-sectional study exploring chemsex behaviors among transgender persons and gathering perspectives from multiple stakeholders to inform the development of transgender-tailored harm reduction services.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Understanding of chemsex patterns, impacts, and service needs among transgender persons for people with hiv prevention, sexually transmitted infections (stis), and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALUnderstanding of chemsex patterns, impacts, and service needs among transgender persons

: During study period (single visit within \~12 months study duration)


Locations(1)

Tangerine Clinic, Institute of HIV Research and Innovation

Pathum Wan, Bangkok, Thailand

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07505875


Related Trials